Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Not All Community Platforms Are Created Equal

February 10, 2026

Picking the right community partner matters, especially now. Discover why Health Union is the gold standard for online health communities.

Leading With Lived Experience: Why Rare Disease Leadership Starts With Patients

December 18, 2025

Learn how building community, recognizing expertise, and meeting patients where they are drive industry leadership and high-impact campaigns.

From Patient Education to Product Innovation: Pam Munnelly on Health Union’s Patient-Centered Approach

December 16, 2025

Bridging Empathy and Innovation: Health Union's Pam Munnelly explains how a deep history in patient education drives their product strategy, from responsible AI to self-advocacy tools.

Content + Conversations: Driving Action Through Contextual Relevance and Engagement

December 2, 2025

See how Health Union's integrated approach, built on Context Quality, delivers superior performance and efficient conversions for healthcare brands.

5 Ways to Make Your Pharma Marketing More Personal

January 20, 2021

Break through the noise and reach and engage people during their unique health journey with our tips to help personalize your pharma marketing strategies.

The Positive Impact of CFTR Modulators: a Year-Over-Year Comparison

December 22, 2020

Current CFTR modulator usage increased from nearly half of respondents in 2019, when three modulators were approved, to 68% in 2020.

Migraine Patient-Reported Survey Data

December 16, 2020

New Health Union survey data show patients experience a very high number of symptoms and triggers, reinforcing that migraine is “more than just a headache.”

Inflammatory Bowel Disease Patient-Reported Survey Data

December 11, 2020

New survey data from Health Union reveals that half of respondents living with inflammatory bowel disease experience symptoms 15+ days per month.

Healthcare Industry Thought Leadership

Contact